TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SPRB

Spruce Biosciences, Inc.

Healthcare · Biotechnology

45.70$ +2.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SPRB
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 99.1% 98.5% 72.7% 97.6% 98.3% 97.8% 98.3%
86.1% 83.6% 96.5% 33.8% 28.6% 92.7% 85.7% 92.2%
86.1% 83.6% 96.5% 70.3% 92.3% 92.7% 85.7% 92.2%
– – 1.1% 1.3% 1.6% – – –
472.8% 753.0% 8.3% 11.9% 20.0% 26.4% 36.2% 19.8%
56.6% 91.7% 6.0% 7.0% 14.5% 23.5% 33.7% 19.0%
– 26.7% 1.7% 0.3% 2.1% 1.8% 4.2% 0.6%
48.2% 40.0% 2.2% 2.2% 1.7% 3.2% 2.9% 1.8%
– 68.1% 1.2% 3.9% 3.8% 1.7% 0.3% –
-372.8% -653.0% 91.7% 88.1% 80.0% 73.6% 63.8% 80.2%
-381.4% -667.1% -37.4% -81.5% -174.3% -189.7% -553.6% -545.5%
0.4% 12.3% 0.4% 0.5% 0.7% 0.5% 1.2% 1.4%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?